# Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDS

> **NCT02155101** · PHASE3 · COMPLETED · sponsor: **University of Liverpool** · enrollment: 120 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** Darunavir
- **DRUG:** ART with 2 NRTIs plus LPV/r (or ATV/r)

## Key facts

- **NCT ID:** NCT02155101
- **Lead sponsor:** University of Liverpool
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02155101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02155101, "Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02155101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*